Combined Quantitative and Qualitative Optical Coherence Tomography Angiography Biomarkers for Predicting Active Neovascular Age-related Macular Degeneration
Abstract Purpose: To investigate choroidal neovascularization (CNV) activity after anti-vascular endothelial growth factor (anti-VEGF) therapy in patients with neovascular age-related macular degeneration (nAMD) by optical coherence tomography angiography (OCTA) and to determine whether combined qualitative and quantitative biomarkers can achieve high predictive accuracy to guide treatment decisions.Methods: Patients diagnosed with type 1 or type 2 CNV via multimodal imaging who had received anti-VEGF treatment were retrospectively reviewed. Qualitative and quantitative CNV responses on OCTA after serial injections were analyzed, and the assessment was correlated with their structural OCT scans. The enrolled eyes were divided into two groups: eyes with exudative signs on structural OCT and those without exudative signs. Results: Fifty-seven eyes of 56 patients were included in the study. Twenty-eight eyes (49.1%) were classified as the “active group”, and 29 eyes (50.9%) were categorized as the “silent group”. Qualitative biomarkers of CNV showed significant differences between the two groups (branching capillaries: 50.0% vs 6.9%, p < 0.001; anastomoses and loops: 78.6% vs 13.8%, p < 0.001; peripheral arcade: 39.3% vs 10.3%, p = 0.015, and hypointense halo: 82.1% vs 41.4%, p = 0.003). A significantly higher vessel density was found in the active group (41.8 ± 12.0% vs 31.0 ± 11.5%, p=0.002). “Anastomoses and loops” and “vessel density” predicted an active CNV status with a probability of 93.7% and achieved the best performance. Conclusions: The combination of two potential biomarkers of CNV on OCTA predicts a high possibility of an active disease status that suggests optimal decisions to treat.